A 2-year, $2 million National Cancer Institute (NCI) award has been given to Boulder-based startup SuviCa, Inc. co-founded by CU Boulder and CU Cancer Center investigator, Dr. Tin Tin Su. Dr. Su hopes to find drugs that augment the effect of radiation to keep cancer at bay.
The Lab Venture Challenge is hosted over two days and broken up into Biosciences on Wednesday, Nov. 13 and Physical Sciences & Engineering on Thursday, Nov. 14. This showcase is the can't-miss event of the year to see CU Boulder's next wave of breakthrough innovations.
The Innosphere Fund announced their second investment in Boulder-based medical device startup company, Aspero Medical, Inc. Aspero has developed the APTM Balloon Overtube for use in gastrointestinal (GI) balloon endoscopy procedures.
A low-cost, high-performance battery chemistry developed by CU Boulder researchers could one day lead to scalable grid-level storage for wind and solar energy that could help electrical utilities reduce their dependency on fossil fuels. Venture Partners helped to file the patent on the innovation.
Inscripta gave its first public presentation at the 2019 Synthetic Biology: Engineering, Evolution & Design (SEED) conference in New York City, where the company offered a peek into their progress toward making “the world’s first scalable platform for benchtop digital genome engineering.”
This technology is being developed by CU Boulder Associate Professor Jianliang Xiao of the Department of Mechanical Engineering in collaboration with Professor Wei Zhang of the Department of Chemistry. Their completely recyclable, self-healing e-skin may one day lead to improvements in human health, robotics, prosthetics and beyond.